I met Irwin Freedberg because of my position at the National Institutes of Health in Bethesda, Maryland, where I was executive secretary/scientific review administrator in the Division of Research Grants, later renamed the Center for Scientific Review. How did it come about that I, a former bench scientist from a far-off discipline, should be so lucky as to land amidst the investigative dermatologists and get to work -in review -with the likes of Irwin and his distinguished colleagues?
In 1946, after a wartime stint in the United States Navy, and under the good auspices of my undergraduate alma mater, Harvard College, I got a job as a chemical technician with the Massachusetts Department of Public Health. What impressed me particularly in all of the hubbub was the quiet concentration of Walter Lever at Harvard Medical School, Department of Physical Chemistry. As he sat among the physical chemists in front of an array of upturned glass butterdish covers from which he harvested little skin-like fibrin precipitates to be deposited in porcelain wells for drying in a hot oven and ultimate weighing. My youthful conclusion from watching Dr. Lever was that research in dermatology did exist, it could be fun, and the boundaries of academic disciplines could be flexible. I liked the possibilities.
Fast-forward through graduate school, postdoc, and a decade of biochemical research to 1961, when I joined the Division of Research Grants at the National Institutes of Health to review grant applications in biomedical research -first as executive secretary of the Arthritis and Metabolic Diseases Program-Project Committee, and then conducting project-grant review with the General Medicine A Study Section. The latter became first GMA-1 and then the Arthritis, Connective Tissue and Skin Study Section, which reviews only grant proposals in dermatology and rheumatology. I had choices along the line, and they were inevitably to stay with review in dermatology. David Bickers must have noted this when he was chairing GMA-1, and he encouraged me to join the Society for Investigative Dermatology. With all this bonding to dermatology research and its community, it was inevitable that I would meet Irwin Freedberg. Irwin attended one meeting of GMA-1 as an ad hoc member, and his performance was great. I tried to recruit him for full membership in GMA-1 but failed. Blame it on timing, his conflicting responsibilities, or whatever. Nevertheless, the channels stayed open, and we spoke often.
Irwin would always help when asked. His commitment to the review process at the National Institutes of Health was strong, and I appreciated being able to count on him.
Our last encounter was at a luncheon in 2004 at the Society for Investigative Dermatology meeting in Providence, Rhode Island. Sitting next to him at the table, I had a fine opportunity to witness how he sparkled and interacted with the assembled guests -lay, scientific, and academic -all of whom he seemed to know quite well.
Many people, myself included, miss him now. (DIGM) . He was the captain who steered the ship through smooth and also sometimes rough waters, expanding the book's already stellar reputation. Dr Thomas B. Fitzpatrick, the founding editor, asked Irwin to join the second (1979) edition of DIGM as a Young Turk to bring fresh blood to a textbook already recognized eight years after the first edition as one of the classics. Irwin served as senior editor of the fifth and sixth editions, published in 1999 and 2003, respectively. As he had done for the Journal of Investigative Dermatology in his role as editor (1972) (1973) (1974) (1975) (1976) (1977) , he brought DIGM to new heights.
Since its inception, DIGM had flourished as a textbook, with each subsequent edition bringing new editors, new authors, new areas of knowledge, and new techniques to the readership. However, Irwin streamlined the book, creating a concise, modern, and up-to-date work reflecting the enormous span of dermatology. Appropriately for its time, the first edition focused on medical dermatology only, but it was later expanded to embrace pediatric dermatology, dermatopathology, and dermatologic surgery. Irwin championed this larger scope and correctly believed that aesthetic concerns regarding the skin and its diseases should also be included to best serve students, practitioners, and, most importantly, patients. He also strengthened the DIGM "signature," the integration of the basic and clinical sciences, by soliciting from contributors new approaches to the biology, structure, and function of the skin. Further, he introduced or expanded sections on evidence-based dermatology, skin changes over the lifespan, dermatologic therapy, dermatologic surgery, and the emerging types of biologic therapy. At the same time, he reduced the roughly 3,000 pages of the unwieldy fourth and fifth editions to 2,600 pages in the most recent sixth edition, upgraded the illustrative material that now is in full color throughout the book, and had all diagrams redrawn for ease of interpretation. Under Irwin's leadership, all the chapters on basic science were extensively rewritten to reflect the enormous advances made during the preceding decade. DIGM being a classic, Irwin advocated renaming it Fitzpatrick's Dermatology in General Medicine to honor Dr Fitzpatrick, who had relinquished his role as a senior editor by the time of the fifth edition.
During production of the fifth and sixth editions, Irwin insisted on proofreading each chapter himself and reviewing the entire two-volume work to eliminate overlaps and redundancies. He was a relentless worker, and only his wife Irene knows how much time and effort he invested in this project. In recognition of his vision and ongoing contributions, after Irwin relinquished his membership of the DIGM editorial board, his co-editors (Lowell A. Goldsmith, Stephen I. Katz, Barbara A. Gilchrest, Amy S. Paller, David J. Leffell, and myself) asked him to remain as an advisor for the seventh edition, now in preparation, and he admirably fulfilled this responsibility until his untimely death.
Irwin was a strong-handed editor whose authority was based on personal integrity as well as on the breadth and depth of his knowledge. A master of both clinical dermatology and basic science, always abreast of recent developments in the field, he himself epitomized DIGM's high standards. Irwin was also a compassionate human being, unfailingly kind and understanding, with limitless and infectious enthusiasm and a unique sense of humor. These characteristics,
Irwin Freedberg and the Changing Times of Academic Medicine
Samuel Hellman Irwin and I were fortunate to become physicians during the early years of the scientific revelations of the "new biology" that began to inform academic medicine. We both were medical house officers at Beth Israel Hospital in Boston during the latter days of Herman Blumgart's reign as chair of medicine. Superb clinical medicine prevailed with great emphasis on clinical-pathological correlation, infectious disease, and, most importantly, the observation, quantification, and manipulation of human physiology. These pursuits were the bedrock of academic medicine. But WatsonCrickery was in the air! At Beth Israel Hospital, Blumgart was succeeded by Howard Hiatt, recently returned from participating in the earliest days of the new biology at the Pasteur Institute. Hiatt brought a whole new vision of academic medicine. Irwin left Beth Israel Hospital during the Blumgart era to do his dermatology training at Massachusetts General Hospital and returned to join Hiatt in implementing a new paradigm of academic medicine. I too left for my training and a junior faculty position at Yale. After I returned to Boston, both Irwin and I were engaged in building our respective academic programs in the clinic and the laboratory. Not only was Irwin building dermatology; under Hiatt's leadership he, H. Richard Nesson, Howard Frazier, and others were remaking academic medicine at Beth Israel.
Irwin had spent the academic year 1961-1962 as a postdoctoral fellow in the biochemistry department at Brandeis University and that of 1969-1970 on a Guggenheim Fellowship at the Weizmann Institute in Israel. Both of these experiences equipped him with the tools of modern molecular science. The titles of two papers authored by Irwin and published by the New England Journal of Medicine capture these two phases of his academic medical research. The first, published in 1957, "The thyroid gland in pregnancy," was the kind of careful observation and quantification of human physiology that was characteristic of the academic medicine of the time. Irwin was the first author, and his coauthors were Milton Hamolsky (later to chair the Department of Medicine at Brown University) and Irwin's uncle A. Stone Freedberg, a distinguished cardiologist interested in the relationship between thyroid function and the heart. The second paper, "Rashes and ribosomes," authored only by Irwin and published just ten years later, offered promise of the practical relevance of basic molecular biology to clinical medicine. in combination with high energy and a passion for perfection, explain the level of excellence he achieved. All that he accomplished, he did for his profession and for us, his extended dermatologic family.
Irwin, we will miss you.
